<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">AAPS PharmSciTech</journal-id><journal-id journal-id-type="iso-abbrev">AAPS PharmSciTech</journal-id><journal-id journal-id-type="pmc-domain-id">793</journal-id><journal-id journal-id-type="pmc-domain">aapspharm</journal-id><journal-title-group><journal-title>AAPS PharmSciTech</journal-title></journal-title-group><issn pub-type="epub">1530-9932</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC3429689</article-id><article-id pub-id-type="pmcid-ver">PMC3429689.1</article-id><article-id pub-id-type="pmcaid">3429689</article-id><article-id pub-id-type="pmcaiid">3429689</article-id><article-id pub-id-type="pmid">22648150</article-id><article-id pub-id-type="doi">10.1208/s12249-012-9803-6</article-id><article-id pub-id-type="publisher-id">9803</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Prodrugs of Theophylline Incorporating Ethyleneoxy Groups in the Promoiety: Synthesis, Characterization, and Transdermal Delivery</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Majumdar</surname><given-names initials="S">Susruta</given-names></name><address><phone>+1-352-5149632</phone><fax>+1-646-4220271</fax><email>majumdas@mskcc.org</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mueller-Spaeth</surname><given-names initials="M">Maren</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sloan</surname><given-names initials="KB">Kenneth B.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Department of Medicinal Chemistry, University of Florida, P.O. Box 100485, Gainesville, Florida 32610 USA </aff><aff id="Aff2"><label/>Laboratory of Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065 USA </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>5</month><year>2012</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2012</year></pub-date><volume>13</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">213455</issue-id><fpage>853</fpage><lpage>862</lpage><history><date date-type="received"><day>12</day><month>12</month><year>2011</year></date><date date-type="accepted"><day>11</day><month>5</month><year>2012</year></date></history><pub-history><event event-type="pmc-release"><date><day>31</day><month>05</month><year>2013</year></date></event><event event-type="pmc-live"><date><day>31</day><month>05</month><year>2013</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2016-04-20 22:14:49.967"><day>20</day><month>04</month><year>2016</year></date></event></pub-history><permissions><copyright-statement>&#169; American Association of Pharmaceutical Scientists 2012</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12249_2012_Article_9803.pdf"/><abstract id="Abs1"><p>Two different types of derivatives of theophylline (Th-H) incorporating ethyleneoxy groups into the promoiety have been synthesized. One is a soft alkyl type where <italic toggle="yes">N</italic>-methyl-<italic toggle="yes">N</italic>-methoxyethyleneoxycarbonylaminomethyl chlorides have been used to alkylate Th-H in the 7 position. The other is in an acyl type where methoxyethyleneoxycarbonyl chlorides have been used to acylate Th-H in the 7 position. All of the prodrugs were more soluble in the lipid isopropyl myristate (IPM) than Th-H, and three were more soluble in water (AQ) than Th-H. The most water-soluble prodrug gave the highest maximum delivery of total species containing Th-H through hairless mouse skin from IPM (maximum flux, J<sub>MMIPM</sub>)&#8212;more than seven times that of Th-H, while the other two gave more than three times that of Th-H. The acyl-type prodrugs delivered only Th-H, while the soft alkyl types delivered 60&#8211;70% Th-H plus intact prodrug. The Roberts&#8211;Sloan equation was able to predict the best performer for each type with an average of the absolute difference between the experimental log&#8201;<italic toggle="yes">J</italic><sub>MMIPM</sub> and calculated log&#8201;<italic toggle="yes">J</italic><sub>MMIPM</sub> (&#916;log&#8201;<italic toggle="yes">J</italic><sub>MMIPM</sub>) of 0.253 log units. The values for the present prodrugs and previously reported prodrugs that had not been previously included in the Roberts&#8211;Sloan data base (<italic toggle="yes">n</italic>&#8201;=&#8201;23) were included in the previous <italic toggle="yes">n</italic>&#8201;=&#8201;71 data base to give <italic toggle="yes">n</italic>&#8201;=&#8201;94. New coefficients for the Roberts&#8211;Sloan equation have been obtained.</p></abstract><kwd-group xml:lang="en"><title>KEY WORDS</title><kwd>ethyleneoxy groups</kwd><kwd>lipid solubility</kwd><kwd>maximum flux</kwd><kwd>Roberts&#8211;Sloan equation</kwd><kwd>theophylline</kwd><kwd>water solubility</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; American Association of Pharmaceutical Scientists 2012</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>